Effect Of Virtual Reality Distraction on Symptom Control and Anxiety in Children With Leukemia
NCT ID: NCT05818748
Last Updated: 2023-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2023-03-30
2024-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality and Fatigue Education
NCT05774379
Music and VR Effects on Pain, Anxiety, and Fear During Oral Mucositis Care in Leukaemic Children
NCT06955338
Effect of Virtual Reality Distraction on Procedural Pain for Children and Adolescents in Onco-Hematology Unit.
NCT03888690
The Effect of Biofeedback-Based Virtual Reality Game on Children
NCT05585840
Effects of Virtual Reality Glasses, Kaleidoscope and Distraction Cards on Pain and Anxiety During Blood Draw in Children
NCT06192498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
When the patients were admitted to the clinic the day before chemotherapy treatment was started, the symptom screening scale and anxiety scale will be applied.
Control Group: The researcher stated that no additional procedure will be applied to the children in the control group and that the symptom screening scale and anxiety measurement will be obtained by explaining that he/she should evaluate the scale every day for 3 days.
VR group; A distraction intervention will be applied for 10-15 minutes once a day with VR glasses. The symptom screening scale and anxiety measurement will be obtained by explaining that he/she should evaluate the scale every day for 3 days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
virtual reality distraction
watching the application by wearing virtual glasses to the child during the 1st, 2nd and 3rd days of chemotherapy treatment
virtual reality
virtual reality distraction
control
no virtual reality distraction
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
virtual reality
virtual reality distraction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 4 weeks after diagnosis (not in the induction phase)
* No need for blood product transfusion (less than 8 mg/dl for hematological malignancies, less than 7 mg/dl for oncological malignancies)
* Consent to voluntarily participate in the study and written consent from the child and parent
Exclusion Criteria
* Having a symptom of nausea and vomiting
* Being in a terminal period
* Undergoing a surgical operation
* Unwillingness to participate in the study
* Having a history of vertigo (having a history of train, motion sickness)
* The child and family do not know Turkish
7 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Dokuz Eylul University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gülçin Özalp Gerçeker
pHD, Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gülçin Özalp Gerçeker, pHD
Role: STUDY_DIRECTOR
Dokuz Eylul University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gülçin Özalp Gerçeker
Izmir, , Turkey (Türkiye)
Figen Yardımcı
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Gülçin Özalp Gerçeker, pHD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VR Ege
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.